| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Wyzga Michael S serves as a Director at MREO and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 1 buy and 5 sells. Those positions are worth an estimated $682K at current prices.
The biggest single holding is EXAS (~$582K) as Director. The recent filings there lean toward selling, a net 34,391 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2023 | XFOR X4 Pharmaceuticals, Inc | Director | Buy | 25,000 | $1.20 | $29,875.00 | +48.4% | -34.0% | -40.1% | |
| Feb 26, 2021 | EXAS Exact Sciences Corp | Director | Sale+OE | 19,021 | $130.11 | $2,474,822.31 | -88.1% | - | - | |
| Jul 31, 2019 | EXAS Exact Sciences Corp | Director | Sale+OE | 5,000 | $117.93 | $589,650.00 | -35.9% | - | - | |
| Feb 28, 2019 | EXAS Exact Sciences Corp | Director | Sell | 500 | $96.00 | $48,000.00 | -5.5% | - | - | |
| Aug 28, 2018 | EXAS Exact Sciences Corp | Director | Sell | 2,468 | $74.85 | $184,729.80 | -21.3% | - | - | |
| May 10, 2018 | EXAS Exact Sciences Corp | Director | Sell | 7,402 | $51.53 | $381,447.27 | -40.3% | - | - |